Results 221 to 230 of about 125,484 (349)

Comparing Proton Pump Inhibitors and Emerging Acid-Suppressive Therapies in Gastroesophageal Reflux Disease: A Systematic Review. [PDF]

Cureus
Ahmed S, Asghar S, Khanzada M, Soxi F, Gundala Raja H, Gul M, Tariq MM, Abid M, Carpenter F.   +8 more
europepmc   +1 more source

A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole [PDF]

, 2001
M. J. R. Janssen, Arnoud H A M van Oijen, André L. M. Verbeek, Jan B.�M.�J. Jansen, W. A. De Boer   +4 more
openalex   +1 more source

Oxidative Phosphorylation in Uncoupled Mitochondria

BioEssays, EarlyView.
Brown adipose tissue (BAT) mediates non‐shivering thermogenesis (NST) through activation of uncoupling protein 1 (UCP1). Due to the uncoupled nature of BAT, oxidative phosphorylation is an underappreciated contributor to NST. Here, we discuss the implications of Inhibitory Factor 1 modulation, an endogenous inhibitor of ATP synthase, for BAT physiology.
Henver S. Brunetta, Marcelo A. Mori, Alexander Bartelt   +2 more
wiley   +1 more source

Antibacterial Properties of Nonsteroidal Anti-inflammatory Drugs and Proton Pump Inhibitors Against Enterococcus faecalis: An In Vitro Comparative Study. [PDF]

Cureus
Parveen S, Mishra N, Akhtar MJ.
europepmc   +1 more source

Reply–potential gastrointestinal effects of longterm acid suppression with proton pump inhibitors [PDF]

, 2001
Loren Laine
openalex   +1 more source

Unveiling the complexity of cellular senescence in cancers: From mechanism to therapeutic opportunities

BMEMat, EarlyView.
This review highlights the complex roles of cellular senescence in cancer progression and suppression, discusses the mechanisms and regulatory pathways involved, and evaluates the efficacy of the “One‐Two punch” sequential treatment approach while addressing emerging challenges in this novel therapeutic strategy.
Qiuming Pan, Ye Zhu, Zhi Ye, Huayang Zhang, Junxi Wang, Guozhong Yi, Zhiyong Li, Rongyang Xu, Luyao Wang, Zhenzhen Wu, Songtao Qi, Guanglong Huang, Shanqiang Qu   +12 more
wiley   +1 more source

Neurological Manifestations Associated With Hypomagnesemia Due to Proton-Pump Inhibitors: A Case Series. [PDF]

Cureus
James L, Rajan G, Devarajan D, Mohan A.
europepmc   +1 more source

Effects of Proton Pump Inhibitors SCH 28080, SPI-447 and Rebeprazole on the Gastric Phospholipid Flippase Activity.

, 2000
Magotoshi Morii, Isao Wanajo, Hidehiro Suzuki, Takanari Murata, Noriaki Takeguchi   +4 more
openalex   +2 more sources

A pH‐responsive charge‐reversal liposome with enhanced biofilm penetration for multimodal synergistic therapy of bacterial infections

BMEMat, EarlyView.
This study develops a pH‐responsive, charge‐reversal liposome for treating bacterial biofilm infections. With enhanced penetration capability, the liposome effectively delivers antibacterial agents into biofilms. By integrating photodynamic and photothermal therapies with antibiotics, it significantly eradicates biofilms and accelerates bacteria ...
Ruyue Li, Bo Liu, Cheng Wang, Zhencheng Sun, Shuyi Lv, Liang Tian, Minghui Xiao, Qinyang Zheng, Linqi Shi, Chunlei Zhu   +9 more
wiley   +1 more source

Comparative in vitro assessment of CYP2C19 inhibition by ilaprazole and conventional proton pump inhibitors using a high throughput fluorometric assay. [PDF]

Sci Rep
Priyadharshini A, Vijayakumar TM, Damodharan N, Vasanth KM, Elaiyaraja A.   +4 more
europepmc   +1 more source